Precigen Inc

Research Precigen Inc (PGEN) on Bullrun: market cap USD 2.11B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPGEN
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 2.11B
• Financial periodFY2025
• RevenueUSD 9.68M
• Revenue growth146.7%
• Net income-USD 250.60M
• Free cash flow-USD 89.83M

Valuation Snapshot

latest market cap is USD 2.11B.

About Precigen Inc

Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. The company offers therapeutic platforms consisting of AdenoVerse platform, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine antigen;

Frequently asked questions

What is Precigen Inc's market cap?

Precigen Inc's market capitalization is USD 2.11B.

What does Precigen Inc do?

Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.